Trophos, a pharmaceutical company leading the MitoTarget Consortium, has announced the launch of MitoTarget Online for the ALS community. The web portal is intended to support patients and caregivers, and help accelerate the discovery of a cure for the disease. The website will contain detailed information on ALS and relevant topics, and will host an exhaustive range of links and resources. The site will also enable the ALS community to follow the details of Trophos’ ALS clinical trials.
Click here to read more.Share this: